Literature DB >> 17478681

A common allele on chromosome 9 associated with coronary heart disease.

Ruth McPherson1, Alexander Pertsemlidis, Nihan Kavaslar, Alexandre Stewart, Robert Roberts, David R Cox, David A Hinds, Len A Pennacchio, Anne Tybjaerg-Hansen, Aaron R Folsom, Eric Boerwinkle, Helen H Hobbs, Jonathan C Cohen.   

Abstract

Coronary heart disease (CHD) is a major cause of death in Western countries. We used genome-wide association scanning to identify a 58-kilobase interval on chromosome 9p21 that was consistently associated with CHD in six independent samples (more than 23,000 participants) from four Caucasian populations. This interval, which is located near the CDKN2A and CDKN2B genes, contains no annotated genes and is not associated with established CHD risk factors such as plasma lipoproteins, hypertension, or diabetes. Homozygotes for the risk allele make up 20 to 25% of Caucasians and have a approximately 30 to 40% increased risk of CHD.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17478681      PMCID： PMC2711874          DOI： 10.1126/science.1142447

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  10 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.

Authors:  Jonathan C Cohen; Eric Boerwinkle; Thomas H Mosley; Helen H Hobbs
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

3.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

4.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-17       Impact factor: 79.321

5.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.

Authors:  Scott F Saccone; Anthony L Hinrichs; Nancy L Saccone; Gary A Chase; Karel Konvicka; Pamela A F Madden; Naomi Breslau; Eric O Johnson; Dorothy Hatsukami; Ovide Pomerleau; Gary E Swan; Alison M Goate; Joni Rutter; Sarah Bertelsen; Louis Fox; Douglas Fugman; Nicholas G Martin; Grant W Montgomery; Jen C Wang; Dennis G Ballinger; John P Rice; Laura Jean Bierut
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

6.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

Authors:  Stefano Romeo; Len A Pennacchio; Yunxin Fu; Eric Boerwinkle; Anne Tybjaerg-Hansen; Helen H Hobbs; Jonathan C Cohen
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

7.  Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.

Authors:  Jonathan C Cohen; Alexander Pertsemlidis; Saleemah Fahmi; Sophie Esmail; Gloria L Vega; Scott M Grundy; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

8.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

Authors:  Ronald G Victor; Robert W Haley; DuWayne L Willett; Ronald M Peshock; Patrice C Vaeth; David Leonard; Mujeeb Basit; Richard S Cooper; Vincent G Iannacchione; Wendy A Visscher; Jennifer M Staab; Helen H Hobbs
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069
  10 in total
  702 in total

1.  Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.

Authors:  Amy L Sherborne; Fay J Hosking; Rashmi B Prasad; Rajiv Kumar; Rolf Koehler; Jayaram Vijayakrishnan; Elli Papaemmanuil; Claus R Bartram; Martin Stanulla; Martin Schrappe; Andreas Gast; Sara E Dobbins; Yussanne Ma; Eamonn Sheridan; Malcolm Taylor; Sally E Kinsey; Tracey Lightfoot; Eve Roman; Julie A E Irving; James M Allan; Anthony V Moorman; Christine J Harrison; Ian P Tomlinson; Sue Richards; Martin Zimmermann; Csaba Szalai; Agnes F Semsei; Daniel J Erdelyi; Maja Krajinovic; Daniel Sinnett; Jasmine Healy; Anna Gonzalez Neira; Norihiko Kawamata; Seishi Ogawa; H Phillip Koeffler; Kari Hemminki; Mel Greaves; Richard S Houlston
Journal:  Nat Genet       Date:  2010-05-09       Impact factor: 38.330

2.  Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls.

Authors:  Michael Preuss; Inke R König; John R Thompson; Jeanette Erdmann; Devin Absher; Themistocles L Assimes; Stefan Blankenberg; Eric Boerwinkle; Li Chen; L Adrienne Cupples; Alistair S Hall; Eran Halperin; Christian Hengstenberg; Hilma Holm; Reijo Laaksonen; Mingyao Li; Winfried März; Ruth McPherson; Kiran Musunuru; Christopher P Nelson; Mary Susan Burnett; Stephen E Epstein; Christopher J O'Donnell; Thomas Quertermous; Daniel J Rader; Robert Roberts; Arne Schillert; Kari Stefansson; Alexandre F R Stewart; Gudmar Thorleifsson; Benjamin F Voight; George A Wells; Andreas Ziegler; Sekar Kathiresan; Muredach P Reilly; Nilesh J Samani; Heribert Schunkert
Journal:  Circ Cardiovasc Genet       Date:  2010-10-05

3.  p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.

Authors:  Céline Cudejko; Kristiaan Wouters; Lucía Fuentes; Sarah Anissa Hannou; Charlotte Paquet; Kadiombo Bantubungi; Emmanuel Bouchaert; Jonathan Vanhoutte; Sébastien Fleury; Patrick Remy; Anne Tailleux; Giulia Chinetti-Gbaguidi; David Dombrowicz; Bart Staels; Réjane Paumelle
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

4.  Stroke Genetics Update: 2011.

Authors:  John W Cole; James F Meschia
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-12-01

Review 5.  Understanding the genetics of coronary artery disease through the lens of noninvasive imaging.

Authors:  Eunice Yang; Jose D Vargas; David A Bluemke
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-01

6.  The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model.

Authors:  Kelly P Downing; Kevin T Nead; Yoko Kojima; Themistocles Assimes; Lars Maegdefessel; Thomas Quertermous; John P Cooke; Nicholas J Leeper
Journal:  Vasc Med       Date:  2013-12-09       Impact factor: 3.239

Review 7.  Genetic and genomic insights into the molecular basis of atherosclerosis.

Authors:  Yaoyu Chen; Jarod Rollins; Beverly Paigen; Xiaosong Wang
Journal:  Cell Metab       Date:  2007-09       Impact factor: 27.287

8.  Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study.

Authors:  Ramin Farzaneh-Far; Beeya Na; Nelson B Schiller; Mary A Whooley
Journal:  Atherosclerosis       Date:  2008-12-30       Impact factor: 5.162

Review 9.  The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects.

Authors:  Anne M Molloy; Lawrence C Brody; James L Mills; John M Scott; Peadar N Kirke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

Review 10.  Linking diabetic vascular complications with LncRNAs.

Authors:  Amy Leung; Vishnu Amaram; Rama Natarajan
Journal:  Vascul Pharmacol       Date:  2018-02-03       Impact factor: 5.773
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.